YKL40 potentially via activating the P38 pathway in decreasing atherosclerotic plaque stability

• Chao Wang,
• Yandong Liu,
• Wei Huan,
• Jianjin Wu,
• Jie Jin,
• Sili Zou,
• Yu Chen,
• Lefeng Qu,
• Yanjie Yin

Affiliations

Chao Wang

1 Department of Vascular and Endovascular Surgery, Changzheng Hospital Affiliated to the Naval Medical University, Shanghai 200003, China

Yandong Liu

1 Department of Vascular and Endovascular Surgery, Changzheng Hospital Affiliated to the Naval Medical University, Shanghai 200003, China

Wei Huan

1 Department of Vascular and Endovascular Surgery, Changzheng Hospital Affiliated to the Naval Medical University, Shanghai 200003, China

Jianjin Wu

1 Department of Vascular and Endovascular Surgery, Changzheng Hospital Affiliated to the Naval Medical University, Shanghai 200003, China

Jie Jin

1 Department of Vascular and Endovascular Surgery, Changzheng Hospital Affiliated to the Naval Medical University, Shanghai 200003, China

Sili Zou

1 Department of Vascular and Endovascular Surgery, Changzheng Hospital Affiliated to the Naval Medical University, Shanghai 200003, China

Yu Chen

3 Clinical Research Institute of Integrative Medicine, Yueyang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

Lefeng Qu

1 Department of Vascular and Endovascular Surgery, Changzheng Hospital Affiliated to the Naval Medical University, Shanghai 200003, China

Yanjie Yin